In colon cancer, DACT2 binding to nuclear β-catenin, preventing it from forming a complex with its partner lymphoid enhancer-binding factor 1, was an important mechanism for DACT2-mediated Wnt/β-catenin signaling inhibition 15. The gene discussed is DACT2; the disease is colonic neoplasm.